Jury awards $2.2 million verdict against Abbott, AbbVie in Humira lawsuit

by Jay Pate

A Chicago jury has awarded $2.2 million to a man who alleges his wife suffered a life-threatening fungal infection as a result of taking the arthritis drug Humira. Humira is one of the world’s best-selling drugs and is primarily used to treat rheumatoid arthritis. The jury found that Abbott Laboratories Inc. and its sister company AbbVie did not properly notify doctors and hospitals of the possible side effects of Humira.

The case was filed by Delores and Milton Tietz of North Dakota. Their lawsuit alleged that Delores took Humira for rheumatoid arthritis from October 2009 through May 2010, when she developed flu-like symptoms. She was eventually diagnosed with disseminated histoplasmosis, a severe infection that can be fatal if untreated.

The lawsuit alleged that the FDA had issued a directive in 2008 instructing drug companies to notify doctors and hospitals that TNF inhibitors such as Humira carried the risk of fungal infections. The Tietzes alleged that Abbott waited almost two years to send out a “Dear Doctor” letter. The trial focused on the 20 months that elapsed between the FDA directive and Abbott’s notification to physicians. The suit alleged that if Abbott had timely notified doctors in accordance with the FDA directive then Delores Tietz’s doctors would have diagnosed her disseminated histoplasmosis earlier.

Most of the other failure-to-warn cases over Humira have been consolidated in Cook County, Illinois Circuit Court, but there is also litigation in federal court in Massachusetts, Texas and Tennessee.

Heygood, Orr & Pearson fighting Big Pharma

The lawyers at Heygood, Orr & Pearson have made it a career priority to hold drug manufacturers accountable and responsible for their actions. As a result, we have spent years holding drug companies and medical device manufacturers responsible for the injuries and deaths caused by their reckless conduct. We have represented hundreds of people regarding dangerous fentanyl pain patches, defective hip and knee implant devices, Yaz, Actos, Avandia and Accutane—to name just some examples.

Heygood, Orr & Pearson is AV-rated, the highest legal and ethical rating available from the leading law firm rating service. Our partners Michael Heygood, Jim Orr, and Eric Pearson are all Board Certified in Personal Injury Trial Law by the Texas Board of Legal Specialization. Mr. Heygood and Mr. Orr are additionally Board Certified in Civil Trial Advocacy Law by the National Board of Trial Advocacy. Our partners been voted by their peers as “Super Lawyers” in the state of Texas for several years in a row.*

At Heygood, Orr & Pearson, we believe that when a drug company sells a drug or medical device that is dangerous and unsafe, they should be held responsible for the damage. In addition, we have the resources and experience to protect a person’s rights and the rights of their loved ones against irresponsible pharmaceutical companies and medical device manufacturers.

If you have been injured or have lost someone you care about because of defective or dangerous prescription drugs or medical devices, you deserve to have the manufacturer held responsible and to receive proper compensation. Contact us for a free consultation by calling toll-free at 1-877-446-9001 or by filling out the free consultation form on this page to find out more about your legal options.


Michael Heygood, James Craig Orr, Jr. and Eric Pearson were selected to the Super Lawyers List, a Thomson Reuters publication, for the years 2003 through 2013.

by Jay Pate

John “Jay” Pate is a licensed attorney who focuses his practice on complex tort litigation involving catastrophic personal injury, wrongful death, medical malpractice, and product liability cases.